cystic fibrosis

Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sun, 12/19/10 - 11:22 am
Vertex Pharmaceuticals
Telaprevir
Merck
hepatitis C
cystic fibrosis
Human Genome Sciences
Benlysta
lupus
MannKind
Afrezza
inhaled insulin
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Bradenton Herald, FL
Mon, 10/25/10 - 08:58 am
Pharmaxis
cystic fibrosis
Bronchitol
Novartis International AG: Novartis receives EU approval recommendation for TOBI® Podhaler®, a fast and simple therapy that helps reduce treatment burden for cystic fibrosis patients
Fri, 09/24/10 - 12:19 pm
Novartis
TOBI Podhaler
cystic fibrosis
Luminex's New Cystic Fibrosis Test
Fri, 08/27/10 - 10:48 am
Luminex
cystic fibrosis
U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis Patients
Medical News Today
Sat, 02/27/10 - 12:42 pm
Gilead Sciences
Cayston
cystic fibrosis
Gilead: A Step in the Right Direction
Seeking Alpha
Wed, 02/24/10 - 05:25 pm
Gilead Sciences
Novartis
Cayston
cystic fibrosis
Gilead’s Inhaled Antibiotic for Lungs Wins Approval
Bloomberg
Tue, 02/23/10 - 11:14 am
Gilead Sciences
Cayston
antibiotics
FDA
cystic fibrosis
Gilead wins FDA panel vote for CF therapy
Fierce Biotech
Fri, 12/11/09 - 10:42 am
FDA
Gilead Sciences
CF
cystic fibrosis
aztreonam
Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial
Yahoo
Mon, 05/4/09 - 11:13 am
Pharmaxis
drug trials
cystic fibrosis
Vertex Plans Human Trial for New Cystic Fibrosis Drug
TheStreet.com
Wed, 03/25/09 - 09:37 am
Vertex Pharmaceuticals
drug trials
Gilead Sciences
Novartis
cystic fibrosis

Pages